Association and clinical implication of the USP10 and MSH2 proteins in non‑small cell lung cancer-Reference-Cited by-同舟云学术

Association and clinical implication of the USP10 and MSH2 proteins in non‑small cell lung cancer

Published:2018-11-15 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Zeng Zhi¹,Li Dan²,Yu Tao³,Huang Yabing¹,Yan Honglin¹,Gu Lijuan⁴,Yuan Jingping¹

Affiliation:

1. Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China

2. Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China

3. Integrated Traditional Chinese and Western Medicine Ward, Oncology Department, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China

4. Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP10 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells;Medical Oncology;2023-12-27

2. Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer;Frontiers in Oncology;2023-03-09

3. Protein degradation: expanding the toolbox to restrain cancer drug resistance;Journal of Hematology & Oncology;2023-01-24

4. The deubiquitinase USP10 protects pancreatic cancer cells from endoplasmic reticulum stress;npj Precision Oncology;2022-12-21

5. Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: Assessing its role in tumor prognosis and immune response;Frontiers in Oncology;2022-09-28